Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
Open Access
- 27 June 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Diabetes Reports
- Vol. 19 (8), 1-9
- https://doi.org/10.1007/s11892-019-1177-7
Abstract
Purpose of Review In this article, we consider advanced technologies for the management of diabetes. Recent Findings Specifically, we pose the question of which should come first: an insulin pump (CSII) or a continuous glucose monitor (CGM)? Historical perspective on both insulin delivery and glucose measurement is provided. Recently published clinical trials are reviewed. Practical issues including quality of life, patient education, and out-of-pocket cost are discussed. Summary Based on available evidence and clinical experience, we favor CGM as a first-line technology recommendation for the treatment of type 1 diabetes (T1D).Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK108611, UC4DK108611)
This publication has 54 references indexed in Scilit:
- Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability DataDiabetes Technology & Therapeutics, 2012
- Continuous glucose monitoring systems for type 1 diabetes mellitusCochrane Database Of Systematic Reviews, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesThe New England Journal of Medicine, 2010
- Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisActa Diabetologica, 2009
- Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusionDiabetic Medicine, 2008
- How hypoglycaemia can affect the life of a person with diabetesDiabetes/Metabolism Research and Reviews, 2008
- Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetesDiabetologia, 2007
- Insulin AnaloguesThe New England Journal of Medicine, 2005
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993